Implementation and outcome of minimally invasive pancreatoduodenectomy in Europe: a registry-based retrospective study A critical appraisal of the first 3 years of the E-MIPS registry.


Journal

International journal of surgery (London, England)
ISSN: 1743-9159
Titre abrégé: Int J Surg
Pays: United States
ID NLM: 101228232

Informations de publication

Date de publication:
24 Jan 2024
Historique:
received: 16 11 2023
accepted: 09 01 2024
medline: 24 1 2024
pubmed: 24 1 2024
entrez: 24 1 2024
Statut: aheadofprint

Résumé

International multicenter audit-based studies focusing on the outcome of minimally invasive pancreatoduodenectomy (MIPD) are lacking. The European registry for Minimally Invasive Pancreatic Surgery (E-MIPS) is the E-AHPBA endorsed registry aimed to monitor and safeguard the introduction of MIPD in Europe. A planned analysis of outcomes among consecutive patients after MIPD from 45 centers in 14 European countries in the E-MIPS registry (2019-2021). Main outcomes of interest were major morbidity (Clavien-Dindo grade ≥3) and 30-day/in-hospital mortality. Overall, 1,336 patients after MIPD were included (835 robot-assisted (R-MIPD) and 501 laparoscopic MIPD (L-MIPD)). Overall, 20 centers performed R-MIPD, 15 centers L-MIPD, and 10 centers both. Between 2019 and 2021, the rate of centers performing L-MIPD decreased from 46.9% to 25%, whereas for R-MIPD this increased from 46.9% to 65.6%. Overall, the rate of major morbidity was 41.2%, 30-day/in-hospital mortality 4.5%, conversion rate 9.7%, POPF grade B/C 22.7%, and PPH grade B/C 10.8%. Median length of hospital stay was 12 days [IQR 8-21]. A lower rate of major morbidity, POPF grade B/C, PPH grade BH/C, DGE grade B/C, percutaneous drainage and readmission was found after L-MIPD. The number of centers meeting the Miami Guidelines volume cut-off of ≥20 MIPDs annually increased from 9 (28.1%) in 2019 to 12 (37.5%) in 2021 (P=0.424). Rates of conversion (7.4% vs. 14.8% P<0.001) and reoperation (8.9% vs. 15.1%) P<0.001) were lower in centers which fulfilled the Miami volume cut-off. During the first 3 years of the pan-European E-MIPS registry, morbidity and mortality rates after MIPD were acceptable. A shift is ongoing from L-MIPD to R-MIPD. Variations in outcomes between the two minimally invasive approaches and the impact of the volume-cut-off should be further evaluated over a longer time period.

Sections du résumé

BACKGROUND BACKGROUND
International multicenter audit-based studies focusing on the outcome of minimally invasive pancreatoduodenectomy (MIPD) are lacking. The European registry for Minimally Invasive Pancreatic Surgery (E-MIPS) is the E-AHPBA endorsed registry aimed to monitor and safeguard the introduction of MIPD in Europe.
MATERIALS AND METHODS METHODS
A planned analysis of outcomes among consecutive patients after MIPD from 45 centers in 14 European countries in the E-MIPS registry (2019-2021). Main outcomes of interest were major morbidity (Clavien-Dindo grade ≥3) and 30-day/in-hospital mortality.
RESULTS RESULTS
Overall, 1,336 patients after MIPD were included (835 robot-assisted (R-MIPD) and 501 laparoscopic MIPD (L-MIPD)). Overall, 20 centers performed R-MIPD, 15 centers L-MIPD, and 10 centers both. Between 2019 and 2021, the rate of centers performing L-MIPD decreased from 46.9% to 25%, whereas for R-MIPD this increased from 46.9% to 65.6%. Overall, the rate of major morbidity was 41.2%, 30-day/in-hospital mortality 4.5%, conversion rate 9.7%, POPF grade B/C 22.7%, and PPH grade B/C 10.8%. Median length of hospital stay was 12 days [IQR 8-21]. A lower rate of major morbidity, POPF grade B/C, PPH grade BH/C, DGE grade B/C, percutaneous drainage and readmission was found after L-MIPD. The number of centers meeting the Miami Guidelines volume cut-off of ≥20 MIPDs annually increased from 9 (28.1%) in 2019 to 12 (37.5%) in 2021 (P=0.424). Rates of conversion (7.4% vs. 14.8% P<0.001) and reoperation (8.9% vs. 15.1%) P<0.001) were lower in centers which fulfilled the Miami volume cut-off.
CONCLUSION CONCLUSIONS
During the first 3 years of the pan-European E-MIPS registry, morbidity and mortality rates after MIPD were acceptable. A shift is ongoing from L-MIPD to R-MIPD. Variations in outcomes between the two minimally invasive approaches and the impact of the volume-cut-off should be further evaluated over a longer time period.

Identifiants

pubmed: 38265434
doi: 10.1097/JS9.0000000000001121
pii: 01279778-990000000-01012
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.

Auteurs

Anouk M L H Emmen (AMLH)

Department of General Surgery, Istituto Ospedaliero Fondazione Poliambulanza, Brescia, Italy.
Amsterdam UMC, location University of Amsterdam, Department of Surgery, Amsterdam, the Netherlands.
Cancer Center Amsterdam, the Netherlands.

Nine de Graaf (N)

Department of General Surgery, Istituto Ospedaliero Fondazione Poliambulanza, Brescia, Italy.
Amsterdam UMC, location University of Amsterdam, Department of Surgery, Amsterdam, the Netherlands.
Cancer Center Amsterdam, the Netherlands.

I E Khatkov (IE)

Department of Surgery, Moscow Clinical Scientific Center, Moscow, Russia.

O R Busch (OR)

Amsterdam UMC, location University of Amsterdam, Department of Surgery, Amsterdam, the Netherlands.
Cancer Center Amsterdam, the Netherlands.

S Dokmak (S)

Department of HPB surgery and liver transplantation, Beaujon hospital, Clichy, France. University Paris Cité.

Ugo Boggi (U)

Division of General and Transplant Surgery, University of Pisa, Pisa, Italy.

Bas Groot Koerkamp (B)

Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.

Giovanni Ferrari (G)

Department of Oncological and Minimally Invasive Surgery, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.

I Q Molenaar (IQ)

Department of Surgery, Regional Academic Cancer Center Utrecht, St. Antonius Hospital and University Medical Center, Utrecht, The Netherlands.

Olivier Saint-Marc (O)

Service de Chirurgie Digestive, Endocrinienne et Thoracique, Centre Hospitalier Universitaire Orleans, Orleans, France.

Marco Ramera (M)

Department of General Surgery, Istituto Ospedaliero Fondazione Poliambulanza, Brescia, Italy.

Daan J Lips (DJ)

Department of Surgery, Medisch Spectrum Twente, Enschede, Netherlands.

J S D Mieog (JSD)

Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.

Misha D P Luyer (MDP)

Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands.

Tobias Keck (T)

Clinic for Surgery, University of Schleswig-Holstein Campus Lübeck, Lübeck, Germany.

Mathieu D'Hondt (M)

Department of Surgery, AZ Groeninge Hospital, Kortrijk, Belgium.

F R Souche (FR)

Département de Chirurgie Digestive (A), Mini-invasive et Oncologique, Hôpital Saint-Eloi, Montpellier, France.

Bjørn Edwin (B)

The Intervention Centre and Department of HPB Surgery, Oslo University Hospital and Institute for Clinical Medicine, Oslo, Norway.

Thilo Hackert (T)

Dept. of General, Visceral and Thoracic Surgery, University Hospital Hamburg-Eppendorf, Hamburg, Germany.

M S L Liem (MSL)

Department of Surgery, Medisch Spectrum Twente, Enschede, Netherlands.

H C van Santvoort (HC)

Department of Surgery, Regional Academic Cancer Center Utrecht, St. Antonius Hospital and University Medical Center, Utrecht, The Netherlands.

Michele Mazzola (M)

Department of Oncological and Minimally Invasive Surgery, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Roeland F de Wilde (RF)

Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.

E F Kauffmann (EF)

Division of General and Transplant Surgery, University of Pisa, Pisa, Italy.

Beatrice Aussilhou (B)

Department of HPB surgery and liver transplantation, Beaujon hospital, Clichy, France. University Paris Cité.

Sebastiaan Festen (S)

Department of Surgery, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands.

R Izrailov (R)

Department of Surgery, Moscow Clinical Scientific Center, Moscow, Russia.

P Tyutyunnik (P)

Department of Surgery, Moscow Clinical Scientific Center, Moscow, Russia.

M G Besselink (MG)

Amsterdam UMC, location University of Amsterdam, Department of Surgery, Amsterdam, the Netherlands.
Cancer Center Amsterdam, the Netherlands.

Mohammad Abu Hilal (M)

Department of General Surgery, Istituto Ospedaliero Fondazione Poliambulanza, Brescia, Italy.

Classifications MeSH